Hybrid TechnologyWJ-MSC + Exosomes

Two mechanisms. Greater potential.

The combination of mesenchymal stem cells derived from Wharton's jelly (WJ-MSCs) and their exosomes in a hybrid, concentrated formulation designed to enhance cellular communication and the body's natural repair processes.

Living, functional cell source

WJ-MSCs provide an active cell source able to respond to the microenvironment and secrete bioactive factors.

Bioactive exosomes

Their exosomes carry proteins, lipids, and signaling molecules that facilitate communication between cells.

Synergistic effect

The cell-vesicle combination works complementarily, enhancing biological benefits.

Concentrated format

Maximum efficacy in a reduced volume, easy to apply and handle.

An advanced platform for the medicine of the future

Developed under the highest quality standards, our hybrid formulation offers a compact, concentrated solution with high regenerative potential.

Biotechnological development

Guaranteed quality

Applications in research and regenerative medicine

Available Presentations

Solutions tailored to your needs

10 MSC
+ 1 Billion
Exosomes

10 million MSC + 1 billion exosomes

25 MSC
+ 2 Billion
Exosomes

25 million MSC + 2 billion exosomes

50 MSC
+ 5 Billion
Exosomes

50 million MSC + 5 billion exosomes

100 MSC
+ 10 Billion
Exosomes

100 million MSC + 10 billion exosomes

Cellular science for a better tomorrow